日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Absolute Bioavailability and Absorption, Distribution, Metabolism, and Excretion of [(14)C]Xevinapant, a Potent, Oral, Small-Molecule IAP Inhibitor

[(14)C]Xevinapant(一种强效口服小分子IAP抑制剂)的绝对生物利用度、吸收、分布、代谢和排泄

Menetrey, Annick; Nicolas-Metral, Valérie; Roubaudi-Fraschini, Marie-Claude; Tat, Tri; Zhao, Yuan; Vugmeyster, Yulia; Venkatakrishnan, Karthik; Rohdich, Felix; Scheible, Holger

P-1229. Assessment of Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment for the Anti-Staphylococcal Antibiotic Afabicin

P-1229. 抗葡萄球菌抗生素阿法比星的药代动力学-药效学 (PK-PD) 目标达成情况评估

Comes-Raga, Ana; Sendra Gisbert, Luis; Marcaida-Benito, Goitzane; Aliño Pellicer, Salvador F; Herrero Cervera, María José; Cameron, David; Dao, Justine; Rubino, Christopher M; Menetrey, Annick; Cammarata, Anthony P; Hammel, Jeffrey P; Dieppois, Guennaelle; Nowakowska, Justyna; Bravo, Juan; VanScoy, Brian D; Hawser, Stephen; Nicolas-Metral, Valerie; Bhavnani, Sujata M

Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial

FUZE多中心、开放标签、II期篮式试验评估Debio 1347在FGFR融合阳性晚期实体瘤患者中的疗效

Grivas, Petros; Garralda, Elena; Meric-Bernstam, Funda; Mellinghoff, Ingo K; Goyal, Lipika; Harding, James J; Dees, E Claire; Bahleda, Rastislav; Azad, Nilofer S; Karippot, Asha; Kurzrock, Razelle; Tabernero, Josep; Kononen, Juha; Ng, Matthew C H; Mehta, Rutika; Uboha, Nataliya V; Bigot, Frédéric; Boni, Valentina; Bowyer, Samantha E; Breder, Valeriy; Cervantes, Andrés; Chan, Nancy; Cleary, James M; Dhawan, Mallika; Eefsen, Rikke L; Ewing, James; Graham, Donna M; Guren, Tormod K; Won Kim, Jin; Koynov, Krassimir; Oh, Do-Youn; Redman, Rebecca; Yen, Chia-Jui; Spetzler, David; Roubaudi-Fraschini, Marie-Claude; Nicolas-Metral, Valerie; Ait-Sarkouh, Rafik; Zanna, Claudio; Ennaji, Abdallah; Pokorska-Bocci, Anna; Flaherty, Keith T

A Phase I, Open-Label, Multicenter, Dose-escalation Study of the Oral Selective FGFR Inhibitor Debio 1347 in Patients with Advanced Solid Tumors Harboring FGFR Gene Alterations

一项针对携带 FGFR 基因改变的晚期实体瘤患者的口服选择性 FGFR 抑制剂 Debio 1347 的 I 期、开放标签、多中心、剂量递增研究

Voss, Martin H; Hierro, Cinta; Heist, Rebecca S; Cleary, James M; Meric-Bernstam, Funda; Tabernero, Josep; Janku, Filip; Gandhi, Leena; Iafrate, A John; Borger, Darrell R; Ishii, Nobuya; Hu, Youyou; Kirpicheva, Yulia; Nicolas-Metral, Valerie; Pokorska-Bocci, Anna; Vaslin Chessex, Anne; Zanna, Claudio; Flaherty, Keith T; Baselga, Jose